Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BPMC

Blueprint Medicines

$71.56

1.8 (2.58%)

16:41
09/24/18
09/24
16:41
09/24/18
16:41
Initiation
Blueprint Medicines initiated at Leerink »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Wednesday
DCPH

Deciphera

$36.16

1.48 (4.27%)

, NVS

Novartis

$85.03

-0.1 (-0.12%)

05:21
09/19/18
09/19
05:21
09/19/18
05:21
Recommendations
Deciphera, Novartis, Blueprint Medicines analyst commentary at Piper Jaffray »

Piper recommends…

DCPH

Deciphera

$36.16

1.48 (4.27%)

NVS

Novartis

$85.03

-0.1 (-0.12%)

BPMC

Blueprint Medicines

$70.95

2.33 (3.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

  • 27

    Nov

Over a week ago
BPMC

Blueprint Medicines

$68.62

-5.35 (-7.23%)

16:40
09/17/18
09/17
16:40
09/17/18
16:40
Initiation
Blueprint Medicines initiated at Guggenheim »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVRO

AvroBio

$37.06

4.14 (12.58%)

, BOLD

Audentes Therapeutics

$34.44

-1.27 (-3.56%)

08:18
09/12/18
09/12
08:18
09/12/18
08:18
Conference/Events
Morgan Stanley to hold a conference »

16th Annual Global…

AVRO

AvroBio

$37.06

4.14 (12.58%)

BOLD

Audentes Therapeutics

$34.44

-1.27 (-3.56%)

ANIK

Anika Therapeutics

$41.40

-0.62 (-1.48%)

VCRA

Vocera

$34.05

0.09 (0.27%)

IONS

Ionis Pharmaceuticals

$44.63

0.1 (0.22%)

CNMD

CONMED

$81.66

0.81 (1.00%)

AMGN

Amgen

$199.51

-3.01 (-1.49%)

SYK

Stryker

$171.78

1.41 (0.83%)

WAT

Waters

$193.87

1.01 (0.52%)

ENDP

Endo

$16.00

-0.13 (-0.81%)

ASMB

Assembly Biosciences

$36.06

-0.27 (-0.74%)

BIIB

Biogen

$337.48

-2.8 (-0.82%)

GILD

Gilead

$72.23

-0.29 (-0.40%)

ABBV

AbbVie

$93.20

-0.64 (-0.68%)

BGNE

BeiGene

$167.00

1.86 (1.13%)

DXCM

DexCom

$146.95

1.83 (1.26%)

GMED

Globus Medical

$53.62

0.47 (0.88%)

NUVA

NuVasive

$70.61

1.48 (2.14%)

SAGE

Sage Therapeutics

$153.74

0.16 (0.10%)

TMO

Thermo Fisher

$236.37

-0.79 (-0.33%)

BPMC

Blueprint Medicines

$76.83

1.15 (1.52%)

EXEL

Exelixis

$17.33

-1.46 (-7.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

  • 26

    Sep

  • 02

    Oct

  • 06

    Oct

  • 17

    Oct

  • 22

    Oct

  • 09

    Nov

  • 19

    Dec

  • 14

    Jan

Over a month ago
BPMC

Blueprint Medicines

$59.52

0.63 (1.07%)

07:14
08/01/18
08/01
07:14
08/01/18
07:14
Hot Stocks
Blueprint Medicines sees its cash and equivalents sufficient into 2H20 »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 14

    Aug

BPMC

Blueprint Medicines

$59.52

0.63 (1.07%)

07:14
08/01/18
08/01
07:14
08/01/18
07:14
Earnings
Blueprint Medicines reports Q2 EPS (62c), consensus ($1.32) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 14

    Aug

DCPH

Deciphera

$41.02

2.34 (6.05%)

, LOXO

Loxo Oncology

$180.15

1.96 (1.10%)

07:26
07/05/18
07/05
07:26
07/05/18
07:26
Initiation
Deciphera, Loxo Oncology, Blueprint Medicines, Mirati Therapeutics initiated at SunTrust »

Deciphera initiated with…

DCPH

Deciphera

$41.02

2.34 (6.05%)

LOXO

Loxo Oncology

$180.15

1.96 (1.10%)

BPMC

Blueprint Medicines

$65.45

0.7 (1.08%)

MRTX

Mirati Therapeutics

$50.05

2.2 (4.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
BPMC

Blueprint Medicines

$69.59

-0.095 (-0.14%)

08:05
06/21/18
06/21
08:05
06/21/18
08:05
Hot Stocks
Blueprint Medicines initiates Voyager Phase 3 clinical trial of Avapritinib »

Blueprint Medicines has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DCPH

Deciphera

$41.00

0.65 (1.61%)

, BPMC

Blueprint Medicines

$72.00

-2.86 (-3.82%)

11:47
06/15/18
06/15
11:47
06/15/18
11:47
Recommendations
Deciphera, Blueprint Medicines analyst commentary at Piper Jaffray »

Piper says Deciphera…

DCPH

Deciphera

$41.00

0.65 (1.61%)

BPMC

Blueprint Medicines

$72.00

-2.86 (-3.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

  • 19

    Jun

BPMC

Blueprint Medicines

$74.86

1.3 (1.77%)

08:09
06/15/18
06/15
08:09
06/15/18
08:09
Hot Stocks
Blueprint Medicines announces updated data from Phase 1 EXPLORER trial »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.